Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan W Day

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Molecular Cancer Research : MCR|February 22, 2020
Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and GrowthAnchit Khanna, Julie A I Thoms, Brett W Stringer, et al.
Oncotarget|February 9, 2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cellsAmanda Tivnan, Tatjana Heilinger, Joanne M Ramsey, et al.
Brain Structure & Function|December 5, 2018
Granule neuron precursor cell proliferation is regulated by NFIX and intersectin 1 during postnatal cerebellar developmentJames Fraser, Alexandra Essebier, Alexander S Brown, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2014
NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical developmentMichael Piper, Guy Barry, Tracey J Harvey, et al.
Cancers|March 15, 2020
MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma CellsAthena F Phoa, Ariadna Recasens, Fadi M S Gurgis, et al.
Nature Neuroscience|September 3, 2013
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptakeWilliam A Flavahan, Qiulian Wu, Masahiro Hitomi, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and ResearchersGeorgia K B Halkett, Lauren J Breen, Melissa Berg, et al.
Oncotarget|April 16, 2016
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastomaBrett W Stringer, Jens Bunt, Bryan W Day, et al.
Oncogene|September 26, 2018
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastomaHeidi A Neubauer, Melinda N Tea, Julia R Zebol, et al.
Cancers|December 20, 2018
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of GlioblastomaCarolin Offenhäuser, Fares Al-Ejeh, Simon Puttick, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Molecular Cancer Research : MCR|February 22, 2020
Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and GrowthAnchit Khanna, Julie A I Thoms, Brett W Stringer, et al.
Oncotarget|February 9, 2017
Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cellsAmanda Tivnan, Tatjana Heilinger, Joanne M Ramsey, et al.
Brain Structure & Function|December 5, 2018
Granule neuron precursor cell proliferation is regulated by NFIX and intersectin 1 during postnatal cerebellar developmentJames Fraser, Alexandra Essebier, Alexander S Brown, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 21, 2014
NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical developmentMichael Piper, Guy Barry, Tracey J Harvey, et al.
Cancers|March 15, 2020
MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma CellsAthena F Phoa, Ariadna Recasens, Fadi M S Gurgis, et al.
Nature Neuroscience|September 3, 2013
Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptakeWilliam A Flavahan, Qiulian Wu, Masahiro Hitomi, et al.
Current Oncology (Toronto, Ont.)|December 22, 2022
Determining the Research Priorities for Adult Primary Brain Tumours in Australia and New Zealand: A Delphi Study with Consumers, Health Professionals, and ResearchersGeorgia K B Halkett, Lauren J Breen, Melissa Berg, et al.
Oncotarget|April 16, 2016
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastomaBrett W Stringer, Jens Bunt, Bryan W Day, et al.
Oncogene|September 26, 2018
Cytoplasmic dynein regulates the subcellular localization of sphingosine kinase 2 to elicit tumor-suppressive functions in glioblastomaHeidi A Neubauer, Melinda N Tea, Julia R Zebol, et al.
Cancers|December 20, 2018
EphA3 Pay-Loaded Antibody Therapeutics for the Treatment of GlioblastomaCarolin Offenhäuser, Fares Al-Ejeh, Simon Puttick, et al.
Pageof 8